BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Biotech Bay

  MicuRx Announces Closing of ¥100M Funding

  Funds will support completion of the ongoing Phase 3 program for its oral antibiotic, contezolid as well as the projected Chinese NDA filing, along with other business activities in China.

  December 6, 2017

   · 

  3 min read
• Drug Development

  PaxVax’s Randomized Placebo-Controlled Study Provides Encouraging Results for a Higher Dose Formulation of Vaxchora (CVD 103-HgR) as a Potential Tool in Containing Cholera Epidemics

  Results support potential future development of a new formulation of Vaxchora as an important additional tool for global cholera control in developing countries.

  December 6, 2017

   · 

  6 min read
• Biotech Beach

  Biocept Announces Pricing of Public Offering of up to 4,925,936 Shares of Common Stock

  No warrants to purchase shares of the Company’s common stock will be issued to the investors in connection with the offering.

  December 6, 2017

   · 

  4 min read
• Biotech Bay

  Varian Halcyon Treatment System Receives ANVISA Registration in Brazil

  This registration allows Varian to market this new system in Brazil.

  December 6, 2017

   · 

  2 min read
• 

  Genetown

  Editas Medicine Prices $50M Offering of Common Stock

  Morgan Stanley is acting as sole book running manager for the offering.

  December 6, 2017

   · 

  3 min read
• Business

  COMPASS Pathways Partners With Worldwide Clinical Trials to Conduct World’s First Large-scale Clinical Trials in Psilocybin Therapy for Treatment-resistant Depression

  December 6, 2017

   · 

  5 min read
• Business

  TetraGenetics and ModiQuest Collaborating for the Discovery of Therapeutic Antibodies Against KCa3.1

  The alliance is focused on the discovery of novel monoclonal antibodies against KCa3.1, a well-validated target for fibrosis, vasculoproliferative disorders and immunomodulation to treat autoimmune and inflammatory disorders.

  December 6, 2017

   · 

  3 min read
• SYGNIS AG Launches TruePrime Apoptotic Cell Free DNA Amplification Kit for the Liquid Biopsy Market

  The kit enables accurate DNA amplification using cfDNA obtained from plasma, serum, urine, CSF, or many other bodily fluids.

  December 6, 2017

   · 

  3 min read
• Business

  Clinigen Plc Directorate Change

  Clinigen announces that Chris Rigg has resigned with immediate effect as a director to seek a CEO role elsewhere.

  December 6, 2017

   · 

  1 min read
• PositiveID Commences Production of Next Generation Caregiver Thermometer With Bluetooth Capability

  Caregiver with Bluetooth will be commercially available in January 2018.

  December 6, 2017

   · 

  4 min read